carvedilol has been researched along with d-alpha tocopherol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Morita, M; Naito, Y; Niki, E; Yoshikawa, T | 1 |
| Bellomo, G; Covini, D; Maggi, E; Marchesi, E; Negro, C; Perani, G | 1 |
| Back, WE; Braun, C; Göttmann, U; Knoll, T; Oltersdorf, J; Schaub, M; van der Woude, FJ | 1 |
| Ichinose, S; Tagami, M; Yamagata, K | 1 |
| Budni, P; Dalmarco, EM; Dalmarco, JB; Frode, TS; Pedrosa, RC; Wilhelm Filho, D | 1 |
| Abdel-Raheem, MH; Al-Rifaay, A; Hasan-Ali, H; Mosad, E; Salama, HS; Salim, SU | 1 |
| Bernabeu, E; Bertera, FM; Buontempo, F; Cagel, M; Chiappetta, DA; Höcht, C; Moretton, MA; Parola, L; Taira, CA; Wegmann, M | 1 |
1 review(s) available for carvedilol and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for carvedilol and d-alpha tocopherol
| Article | Year |
|---|---|
Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Antioxidants; Autoantibodies; Carbazoles; Carvedilol; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Propanolamines; Vasodilator Agents; Vitamin E | 1996 |
7 other study(ies) available for carvedilol and d-alpha tocopherol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of plasma lipid oxidation induced by peroxyl radicals, peroxynitrite, hypochlorite, 15-lipoxygenase, and singlet oxygen by clinical drugs.
Topics: Animals; Antioxidants; Antipyrine; Arachidonate 15-Lipoxygenase; Edaravone; Free Radicals; Hypochlorous Acid; Lipid Metabolism; Lipids; Mice; Oxidants; Oxidation-Reduction; Peroxides; Peroxynitrous Acid; Plasma; Probucol; Singlet Oxygen | 2016 |
Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol.
Topics: alpha-Tocopherol; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Carbazoles; Carvedilol; Graft Rejection; Kidney Transplantation; Male; Oxidative Stress; Propanolamines; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 2003 |
Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antioxidants; Carbazoles; Carvedilol; Cell Death; Cell Hypoxia; Cells, Cultured; Cerebral Cortex; Dipyridamole; Hypertension; Microscopy, Electron; Neurons; Neuroprotective Agents; Oxygen; Propanolamines; Rats; Rats, Inbred SHR; Reperfusion Injury; Stroke; Vasodilator Agents; Vitamin E | 2004 |
Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Biomarkers; Carbazoles; Carvedilol; Chagas Disease; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oxidative Stress; Propanolamines; Prospective Studies; Time Factors; Treatment Outcome; Vitamin E; Young Adult | 2013 |
Antiapoptotic and antioxidant effects of carvedilol and vitamin E protect against diabetic nephropathy and cardiomyopathy in diabetic Wistar albino rats.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Apoptosis; Carbazoles; Carvedilol; Diabetic Cardiomyopathies; Diabetic Nephropathies; Gene Expression Regulation; Male; Myocardium; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Vitamin E | 2015 |
Novel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Carbazoles; Carvedilol; Chemistry, Pharmaceutical; Drug Carriers; Male; Micelles; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyethylene Glycols; Polymers; Polyvinyls; Propanolamines; Rats; Rats, Wistar; Solubility; Vitamin E | 2017 |